HIKAL  
                     | 
                    
                
The Current P/B Ratio of HIKAL  is 2.39.
                
| Share Price | ₹244.6 | Nov 03,2025 | 
| Market Cap | ₹3,015.3 Cr | |
| Book Value | ₹1,262.3 Cr | Mar2025 - Consolidated Results | 
| Price/Book | 2.39x | Calculated as MarketCap/Book Value | 
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of HIKAL
                    P/B = 
                    Market Capitalization 
                    / Book Value 
                    
                    or, using per-share numbers:
                    
                    P/B = Stock Price / 
                    Book Value Per Share 
                
               
                                     Current Market Cap [ ₹3,015.3 Cr] as on Nov 03,2025                     
                    (/) Book Value [ ₹1,262.3 Cr] based on Mar2025 - Consolidated Results
                                    
                
                (=) P/B Ratio [ 2.39x ]
            
Thus, for HIKAL , the investors are currently willing to pay '2.39 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of HIKAL !
The chart below summarizes the trend in P/B Ratio of HIKAL over the last five years.
Historical PB (Price/Book ) ratio chart of HIKAL
PB Ratio Performance Analysis for HIKAL
- HIKAL 's p/b ratio for fiscal years ending Mar2025 to Mar2021 averaged 3.26x.
- HIKAL 's operated at median p/b ratio of 3.07x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, HIKAL 's p/b ratio peaked in Mar2022 at 4.65x.
- HIKAL 's p/b ratio hit its five-year low in Mar2021 of 1.9x.
How does HIKAL 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap | 
|---|---|---|---|
| HIKAL | 1,262.30 | 2.39 | 3,015.3 | 
| SUN PHARMACEUTICAL INDUSTRIES LTD | 72,218.00 | 5.67 | 409,626.0 | 
| DIVIS LABORATORIES LTD | 14,969.00 | 12.07 | 180,669.0 | 
| CIPLA LTD | 31,079.30 | 3.93 | 122,103.0 | 
| TORRENT PHARMACEUTICALS LTD | 7,590.69 | 16.18 | 122,793.0 | 
| DR REDDYS LABORATORIES LTD | 33,404.90 | 2.99 | 99,857.4 | 
| MANKIND PHARMA LTD | 14,288.70 | 6.94 | 99,138.4 | 
| ZYDUS LIFESCIENCES LTD | 23,953.10 | 4.12 | 98,686.4 | 
| LUPIN LTD | 17,119.50 | 5.30 | 90,706.1 | 
| AUROBINDO PHARMA LTD | 32,653.30 | 2.06 | 67,259.7 | 
| ABBOTT INDIA LTD | 4,204.27 | 14.70 | 61,800.2 | 
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs HIKAL 's P/B Ratio
| Top 10 Industry Peers | PB Ratio | 
|---|---|
| Min industry PB | 2.06x | 
| Max industry PB | 16.18x | 
| Median industry PB | 5.30x | 
| Average industry PB | 6.94x | 
You may also like the below Video Courses